Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Nanomaterials As Nanocarriers: A Critical Assessment Why These Are Multi-chore Vanquisher In Breast Cancer Treatment
Sania Naz, H. Shahzad, Attarad Ali, M. Zia
Published 2018 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Abstract Breast cancer is a group of diseases with various subtypes and leads to high mortality throughout the globe. Various conventional techniques are in practice to cure breast cancer but these techniques are linked with various shortcomings. Mostly these treatments are not site directed and cause toxicity towards normal cells. In order to overcome these issues, we need smart system that can deliver anticancer drugs to specific sites. Targeted drug delivery can be achieved via passive or active drug delivery using nanocarriers. This mode of drug delivery is more effective against breast cancer and may help in the reduction of mortality rate. Potentially used nanocarriers for targeted drug delivery belong to organic and inorganic molecules. Various FDA approved nano products are in use to cure breast cancer. However, body’s defense system is main limitation for potential use of nano systems. However, this can be overcome by surface modification of nanocarriers. In this review, breast cancer and its types, targeted drug delivery and nanocarriers used to cure breast cancer are discussed. By progressing nanotechnology, we will be able to fight against this life threatening issue and serve the humanity, which is the basic aim of scientific knowledge.
This paper references
Catalytic Properties and Biomedical Applications of Cerium Oxide Nanoparticles.
Carl D. Walkey (2015)
Immunonanoshells for targeted photothermal ablation of tumor cells
Amanda R. Lowery (2006)
Synergistic enhancement effect of magnetic nanoparticles on anticancer drug accumulation in cancer cells.
Renyun Zhang (2006)
Antitumor activity of colloidal silver on MCF-7 human breast cancer cells
M. Franco-Molina (2010)
Enhanced anticancer potency using an acid-responsive ZnO-incorporated liposomal drugdelivery system. Nanoscale
N Tripathy (2015)
Nickel nanowires induced and reactive oxygen species mediated apoptosis in human pancreatic adenocarcinoma cells
M. Hossain (2011)
Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer.
M. Loebinger (2009)
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
C. Oerlemans (2010)
Drug delivery systems: past, present, and future.
R. Mainardes (2004)
Stimuli-responsive nanocarriers for drug delivery.
S. Mura (2013)
Tamoxifen for early breast cancer: An overview of the randomised trials
O. Abe (1998)
Applications of Nanotechnology in Cancer: A literature Review on Imaging and Treatment
M. Bala (2017)
The promise of nanotechnology for solving clinical problems in breast cancer
S. Grobmyer (2011)
Designing dendrimers for biological applications
C. C. Lee (2005)
Nanoparticle delivery of cancer drugs.
A. Wang (2012)
Nanoparticles-mediated drug delivery approaches for cancer targeting: a review
S. Sultana (2013)
Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland.
S. Kelleher (2011)
Arsenic Induces Functional Re-Expression of Estrogen Receptor α by Demethylation of DNA in Estrogen Receptor-Negative Human Breast Cancer
J. Du (2012)
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials
AK Gupta (2005)
Basis for design and development of platinum(IV) anticancer complexes.
M. Hall (2007)
Advances of cancer therapy by nanotechnology.
X. Wang (2009)
Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells.
N. Stasko (2007)
Gold Nanocages: Synthesis, Properties, and Applications
S. Skrabalak (2009)
Bio‐distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice
Suzanne Marie Hirst (2013)
Locally advanced breast cancer
N. E. El Saghir (2008)
Emerging Implications of Nanotechnology on Cancer Diagnostics and Therapeutics
Sumita Thakur (2012)
Controlling tumor growth by modulating endogenous production of reactive oxygen species.
A. Laurent (2005)
Cerium oxide nanoparticles in cancer
Y. Gao (2014)
The nanomechanical signature of breast cancer.
M. Plodinec (2012)
Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles
Yan Chen (2011)
Ce³+ ions determine redox-dependent anti-apoptotic effect of cerium oxide nanoparticles.
I. Celardo (2011)
Zinc oxide nanoparticles as selective killers of proliferating cells
Liuba Taccola (2011)
Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin
J. Wang (2011)
Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles.
F. Hu (2006)
Cellular Toxicity of TiO2 Nanoparticles in Anatase and Rutile Crystal Phase
Chan Jin (2010)
PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes.
Rasmus Foldbjerg (2009)
Enhanced anticancer potency using an acid-responsive ZnO-incorporated liposomal drug-delivery system.
N. Tripathy (2015)
Targeted systemic chemotherapy using magnetic liposomes with incorporated adriamycin for osteosarcoma in hamsters.
T. Kubo (2001)
Diffusion of univalent ions across the lamellae of swollen phospholipids.
A. Bangham (1965)
Copper oxide nanoparticles induce oxidative stress and cytotoxicity in airway epithelial cells.
Baher Fahmy (2009)
A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer
Andrea L. Kasinski (2015)
A Novel Lytic Peptide Composed of dl-Amino Acids Selectively Kills Cancer Cells in Culture and in Mice*
N. Papo (2003)
Role of nanotechnology in targeted drug delivery and imaging: a concise review.
O. Koo (2005)
Smart polymers in drug delivery systems on crossroads: Which way deserves following?
M. Hruby (2015)
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas.
I. Ray-Coquard (2009)
Ferumoxytol: a silver lining in the treatment of anemia of chronic kidney disease or another dark cloud?
A. Pai (2012)
Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using chitosan nanocarrier.
Pallab Sanpui (2011)
Recent trends in breast cancer incidence and mortality
J. Lacey (2002)
Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy.
F. Dilnawaz (2010)
Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors
S. Akshintala (2015)
Plasma synthesis of carboniron magnetic nanoparticles and immobilization of doxorubicin for targeted drug delivery
Y Ma (2006)
Anisotropic metal nanoparticles: Synthesis, assembly, and optical applications.
C. Murphy (2005)
O. Farokhzad (2004)
Engineered cobalt oxide nanoparticles readily enter cells.
E. Papis (2009)
Immunotherapy of cancer.
M. Woodruff (1970)
Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal goldrhTNF nanomedicine
SK Libutti (2010)
Multiple release kinetics of targeted drug from gold nanorod embedded polyelectrolyte conjugates induced by near-infrared laser irradiation.
Tsung-Rong Kuo (2010)
Ultrasound mediated transdermal drug delivery.
Aharon Azagury (2014)
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC).
A. Awada (2014)
Global cancer statistics
D. Parkin (1999)
Arsenic Trioxide Inhibits Cell Growth and Induces Apoptosis through Inactivation of Notch Signaling Pathway in Breast Cancer
J. Xia (2012)
Multifunctional DNA-based biomemory device consisting of ssDNA/Cu heterolayers.
Taek Lee (2011)
Synthesis and DNA‐Damaging Properties of Cisplatin‐N‐Mustard Conjugates
S. Schiesser (2015)
Development of Magnetic Nanostructured Silica-Based Materials as Potential Vectors for Drug-Delivery Applications
M. Arruebo (2006)
Enhanced anticancer efficacy by ATP-mediated liposomal drug delivery.
Ran Mo (2014)
Pharmacokinetic considerations for targeted drug delivery.
F. Yamashita (2013)
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
F. Kratz (2008)
A role of ZnO nanoparticle electrostatic properties in cancer cell cytotoxicity
D. Wingett (2016)
Size and shape effects in the biodistribution of intravascularly injected particles.
P. Decuzzi (2010)
Best Practices in Cancer Nanotechnology: Perspective from NCI Nanotechnology Alliance
W. Zamboni (2012)
Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor
A. Quintana (2004)
Applications of Nanotechnology in Cancer: A Literature Review of Imaging and
A. Narayana (2014)
Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors
J. Kopecka (2016)
Light-triggered liposomal release: membrane permeabilization by photodynamic action.
A. Pashkovskaya (2010)
Invasive breast cancer.
I. Andersson (2011)
Functional repression of estrogen receptor a by arsenic trioxide in human breast cancer cells.
Gui-Cai Chen (2002)
Direct Evidence for Hydroxyl Radical Scavenging Activity of Cerium Oxide Nanoparticles
Ying Xue (2011)
Mucin‐type O‐glycans in human colon and breast cancer: glycodynamics and functions
I. Brockhausen (2006)
Hydroxyl radical is the active species in photochemical DNA strand scission by bis(peroxo)vanadium(V) phenanthroline.
M. Sam (2004)
Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum.
P. Couvreur (1979)
Near-infrared light-triggered, targeted drug delivery to cancer cells by aptamer gated nanovehicles.
X. Yang (2012)
Aptamer-guided silver-gold bimetallic nanostructures with highly active surface-enhanced Raman scattering for specific detection and near-infrared photothermal therapy of human breast cancer cells.
P. Wu (2012)
Metal complex interactions with DNA.
Benjamin J Pages (2015)
Nanotechnology: Intelligent Design to Treat Complex Disease
P. Couvreur (2006)
[Breast carcinoma in men].
Daniel Sera (1988)
The footprint of urban heat island effect in China
Decheng Zhou (2015)
Cuprous oxide nanoparticles selectively induce apoptosis of tumor cells
Y. Wang (2012)
Functional polymers: from plastic electronics to polymer-assisted therapeutics
J. Fréchet (2005)
Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy.
P. Parhi (2012)
Triggered release of siRNA from poly(ethylene glycol)-protected, pH-dependent liposomes.
D. Auguste (2008)
Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide
X. Wang (2011)
Dendronized gold nanoparticles for siRNA delivery.
S. Kim (2012)
Proinflammatory effects of bare and PEGylated ORMOSIL-, PLGA- and SUV-NPs on monocytes and PMNs and their modulation by f-MLP.
Daniela Segat (2011)
Doxorubicin: the good, the bad and the ugly effect.
C. Carvalho (2009)
Effect of reducing agent on the synthesis of nickel nanoparticles
P. Khanna (2009)
A novel glucose biosensor based on the nanoscaled cobalt phthalocyanine-glucose oxidase biocomposite.
K. Wang (2005)
Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine
J Colon (2010)
Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles.
Cory Hanley (2008)
Liposomes: the Babraham connection.
A. Bangham (1993)
Reactive oxygen species, antioxidants and signaling in plants
P. Ahmad (2009)
Composite poly(vinyl alcohol)/poly(vinyl acetate) electrospun nanofibrous mats as a novel wound dressing matrix for controlled release of drugs
Marziyeh Jannesari (2011)
Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549
Rasmus Foldbjerg (2010)
Development by self-digestion: molecular mechanisms and biological functions of autophagy.
B. Levine (2004)
DNA binders in clinical trials and chemotherapy.
Asfa Ali (2014)
Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.
J. Baselga (2012)
The Optical Properties of Metal Nanoparticles: The Influence of Size, Shape, and Dielectric Environment
K. Kelly (2003)
Controlled drug delivery system based on magnetic hollow spheres/polyelectrolyte multilayer core-shell structure.
Y. Zhang (2006)
Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer.
N. Chattopadhyay (2010)
Drug loaded magnetic nanoparticles for cancer therapy
R. Jurgons (2006)
Targeted Nanoparticles for Cancer Therapy: Promises and Challenges
K. Nguyen (2011)
Molecular mechanisms of cisplatin resistance
L. Galluzzi (2012)
HER2-Positive Breast Cancer
Ryan H Engel (2012)
Emerging nanopharmaceuticals. Nanomed
WE Bawarski (2008)
Dendrimers in solution: insight from theory and simulation.
M. Ballauff (2004)
Synthesis of ultrastable copper sulfide nanoclusters via trapping the reaction intermediate: potential anticancer and antibacterial applications.
Hongyin Wang (2015)
Targeted cancer therapy with novel high drug-loading nanocrystals.
F. Liu (2010)
Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update.
H. Burstein (2014)
Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines.
G. Vance (2009)
Formation of NiS and CoS semiconductor nanoparticles inside mordenite-type zeolite
M. Sadjadi (2007)
Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications.
A. R. Menjoge (2010)
Bone imaging in metastatic breast cancer.
T. Hamaoka (2004)
Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer
T. Zagar (2014)
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
A. Gupta (2005)
Liposomes : a practical approach
R. New (1990)
Zoledronic acid induces apoptosis via stimulating the expressions of ERN1, TLR2, and IRF5 genes in glioma cells
C. Biray Avci (2015)
Magnetosome-like ferrimagnetic iron oxide nanocubes for highly sensitive MRI of single cells and transplanted pancreatic islets
N. Lee (2011)
Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases.
M. Malhotra (2013)
Lyophilized Paclitaxel Magnetoliposomes as a Potential Drug Delivery System for Breast Carcinoma via Parenteral Administration: In Vitro and in Vivo Studies
J. Zhang (2005)
Surface modification of cobalt oxide nanoparticles using phosphonomethyl iminodiacetic acid followed by folic acid: a biocompatible vehicle for targeted anticancer drug delivery
S. Chattopadhyay (2013)
Noble Metal Nanoparticles Applications in Cancer
João Conde (2012)
Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.
B. Takkouche (2008)
Early breast cancer.
B. M. Truscott (1970)
Molecular responses of human lung epithelial cells to the toxicity of copper oxide nanoparticles inferred from whole genome expression analysis.
N. Hanagata (2011)
Oxaliplatin-chitosan nanoparticles induced intrinsic apoptotic signaling pathway: a "smart" drug delivery system to breast cancer cell therapy.
R. Vivek (2014)
Nanoshell-enabled photothermal cancer therapy: impending clinical impact.
Surbhi Lal (2008)
Mechanistic Investigation of the Biological Effects of SiO₂, TiO₂, and ZnO Nanoparticles on Intestinal Cells.
M. I. Setyawati (2015)
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
Willie E. Bawarski (2008)
Enhancing the efficiency of gold nanoparticles treatment of cancer by increasing their rate of endocytosis and cell accumulation using rifampicin.
Moustafa R K Ali (2014)
Polymer-based nanocapsules for drug delivery.
C. E. Mora-Huertas (2010)
Study on the enhanced cellular uptake effect of daunorubicin on leukemia cells mediated via functionalized nickel nanoparticles.
Dadong Guo (2009)
Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation.
J. Zhang (2005)
Nano-oncology: drug delivery, imaging, and sensing
N. G. Portney (2006)
Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers.
C. Boswell (2008)
Solubility Enhancement of Indomethacin with Poly(amidoamine) Dendrimers and Targeting to Inflammatory Regions of Arthritic Rats
A. Chauhan (2004)
Nanoparticleaptamer bioconjugates a new approach for targeting prostate cancer cells
OC Farokhzad (2004)
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
L. R. Hirsch (2003)
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential
M. Immordino (2006)
Theranostic nanoshells: from probe design to imaging and treatment of cancer.
R. Bardhan (2011)
Polymers for the sustained release of proteins and other macromolecules
R. Langer (1976)
Doxorubicin loaded magnetic polymersomes: theranostic nanocarriers for MR imaging and magneto-chemotherapy.
Charles Sanson (2011)
Antibacterial and anticancer properties of NiO nanoparticles by co-precipitation method
L. Umaralikhan (2016)
Biodegradable longcirculating polymeric nanospheres
R Gref (1994)
Dendrimers in drug research.
U. Boas (2004)
Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide.
Susan F Murphy (2016)
Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?
R. Goshen (2000)
Inhibition of cell proliferation and the action mechanisms of arsenic trioxide (As2O3) on human breast cancer cells
S. K. Chow (2004)
TAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance.
Hsiangkuo Yuan (2012)
Potential of using cerium oxide nanoparticles for protecting healthy tissue during accelerated partial breast irradiation (APBI).
Z. Ouyang (2016)
Carbon nanotube-DNA nanoarchitectures and electronic functionality.
X. Wang (2006)
Evaluation of selective tumor detection by clinical magnetic resonance imaging using antibody-conjugated superparamagnetic iron oxide.
Takayoshi Koyama (2012)
Locally advanced breast cancer.
F. Esteva (1999)
Biodegradable polymeric nanoparticles based drug delivery systems.
A. Kumari (2010)
Histological and molecular types of breast cancer: is there a unifying taxonomy?
B. Weigelt (2009)
Tumour and dendrimers: a review on drug delivery aspects
A. Agarwal (2008)
Gold nanoparticles as novel agents for cancer therapy.
S. Jain (2012)
Understanding the pathway of antibacterial activity of copper oxide nanoparticles
S. Meghana (2015)
Pharmacokinetics of Pegylated Liposomal Doxorubicin
A. Gabizon (2003)
Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma
W. Zamboni (2003)
Gold Nanoshell Nanomicelles for Potential Magnetic Resonance Imaging, Light‐Triggered Drug Release, and Photothermal Therapy
Y. Ma (2013)
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
Jaehyun Lee (2007)
MM-398 achieves primary endpoint of overall survival in phase III study in patients with gemcitabine refractory metastatic pancreatic cancer.
M. Saif (2014)
A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
M. Hussain (2004)
Blockage of Multidrug Resistance-Associated Proteins Potentiates the Inhibitory Effects of Arsenic Trioxide on CYP1A1 Induction by Polycyclic Aromatic Hydrocarbons
L. Vernhet (2003)
Arsenic trioxide induces the apoptosis of human breast cancer MCF-7 cells through activation of caspase-3 and inhibition of HERG channels.
Y. Wang (2011)
Tamoxifen for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group (1998)
Cancer nanotechnology: application of nanotechnology in cancer therapy.
R. Misra (2010)
Nanotechnology and human health: risks and benefits
A. G. Cattaneo (2010)
Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles.
Atul Asati (2010)
Redox-triggered contents release from liposomes.
W. Ong (2008)
Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2.
J. Colon (2010)
Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles.
I. El-Sayed (2006)
Controlled synthesis of multilayered gold nanoshells for enhanced photothermal therapy and SERS detection.
Yongping Gao (2015)
Detection and imaging of aggressive cancer cells using an epidermal growth factor receptor (EGFR)-targeted filamentous plant virus-based nanoparticle.
Paul L Chariou (2015)
Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro.
M. Krieger (2010)
The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction
Cory Hanley (2009)
FePt nanoparticles as an Fe reservoir for controlled Fe release and tumor inhibition.
C. Xu (2009)
Evaluation of the antitumor activity by Ni nanoparticles with verbascoside
Mingyue Chen (2013)
Transferrin-Targeted Nanoparticles Containing Zoledronic Acid as a Potential Tool to Inhibit Glioblastoma Growth.
G. Salzano (2016)
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
Fatemeh Madani (2011)
American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.
H. Burstein (2010)
pH-responsive NIR enhanced drug release from gold nanocages possesses high potency against cancer cells.
P. Shi (2012)
Arsenic trioxide: mechanisms of action.
K. Davison (2002)
Mechanisms of protein assembly: lessons from minimalist models.
Y. Levy (2006)
Bio-imaging and Photodynamic Therapy with Tetra Sulphonatophenyl Porphyrin (TSPP)-TiO2 Nanowhiskers: New Approaches in Rheumatoid Arthritis Theranostics
C. Zhao (2015)
Nanotechnology applications in cancer.
Shuming Nie (2007)
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
C. Vauthier (2008)
Interplay between autophagy and apoptosis mediated by copper oxide nanoparticles in human breast cancer cells MCF7.
Dipranjan Laha (2014)
Iron oxide nanoparticles for sustained delivery of anticancer agents.
Tapan Jain (2005)
Cytotoxicity of Biologically Synthesized Silver Nanoparticles in MDA-MB-231 Human Breast Cancer Cells
S. Gurunathan (2013)
Plasma synthesis of carbon-iron magnetic nanoparticles and immobilization of doxorubicin for targeted drug delivery
Y. Ma (2004)
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC).
A. Awada (2014)
Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm.
T. Xia (2006)
Disposition of Drugs in Block Copolymer Micelle Delivery Systems
H. M. Aliabadi (2008)
Analysis on the current status of targeted drug delivery to tumors.
I. Kwon (2012)
Arsenic trioxide - An old drug rediscovered.
A. Emadi (2010)
Apoptosis, Chemoresistance, and Breast Cancer: Insights From the MCF-7 Cell Model System
Rebecca Simstein (2003)
Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation
K. Kono (2013)
Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics.
M. Dwivedi (2015)
Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species
M. Akhtar (2012)
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
F. Gu (2008)
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
S. Libutti (2010)
In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery
S. Sahu (2010)
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.
Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia
E. Lengfelder (2012)
Invasive breast cancer.
R. Carlson (2011)
C1-symmetrical titanium(IV) complexes of salan ligands with differently substituted aromatic rings: enhanced cytotoxic activity.
H. Glasner (2014)
Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications
C. Xu (2014)
Nanotechnology for breast cancer therapy
T. Tanaka (2009)
Synthesis of uniform ferrimagnetic magnetite nanocubes.
D. Kim (2009)
The discovery of the elements. XVI. The rare earth elements
M. E. Weeks (1932)
The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells.
Yi-Hong Hsin (2008)
Ce3þ ions determine redox-dependent anti-apoptotic effect of cerium oxide nanoparticles
I Celardo (2011)
FePt@CoS2 Yolk—Shell Nanocrystals as a Potent Agent to Kill HeLa Cells.
J. Gao (2007)
Nanoparticles in Medicine: Therapeutic Applications and Developments
L. Zhang (2008)
Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model
Muthu Irulappan Sriram (2010)
Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.
P. Pradhan (2010)
Immunotargeted nanoshells for integrated cancer imaging and therapy.
C. Loo (2005)
Phase I study of liposomal annamycin
D. Booser (2000)
Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial.
D. Kauer-Dorner (2012)
Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system.
Weilun Ke (2008)
Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology.
M. Daniel (2004)
Magnetic PECA nanoparticles as drug carriers for targeted delivery: Synthesis and release characteristics
J. Yang (2006)
Liposomal encapsulated anti-cancer drugs.
R. Hofheinz (2005)
Size and Chemistry Controlled Cobalt-Ferrite Nanoparticles and Their Anti-proliferative Effect against the MCF-7 Breast Cancer Cells
S. Ansari (2016)
Gp60 Activation Mediates Albumin Transcytosis in Endothelial Cells by Tyrosine Kinase-dependent Pathway*
C. Tiruppathì (1997)
HER2-positive breast cancer
S. Loibl (2017)
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.
N. Hylton (2012)
Picomolar sensitivity MRI and photoacoustic imaging of cobalt nanoparticles
L. Bouchard (2009)
Recent advances with liposomes as pharmaceutical carriers
V. Torchilin (2005)
Identification of novel caspase/autophagy‐related gene switch to cell fate decisions in breast cancers
L-L Fu (2013)
Dumbbell-like Au-Fe3O4 nanoparticles for target-specific platin delivery.
C. Xu (2009)
Nickel nanoparticle-induced dose-dependent cyto-genotoxicity in human breast carcinoma MCF-7 cells
M. Ahamed (2014)
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
Rajni Sinha (2006)
Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes.
Avi Schroeder (2009)
Applications of magnetic targeting in diagnosis and therapy--possibilities and limitations: a mini-review.
W. Schuett (1997)
Lipoplatin Formulation Review Article
G. Stathopoulos (2012)
Cancer nanotechnology: opportunities and challenges
M. Ferrari (2005)
The anticancer activity of chloroquine-gold nanoparticles against MCF-7 breast cancer cells.
Prachi Joshi (2012)
Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.
V. Torchilin (2009)
Dendrimer grafts for delivery of 5-fluorouracil.
P. Tripathi (2002)
Tshuva EY. C 1-Symmetrical Titanium (IV) Complexes of Salan Ligands with Differently Substituted Aromatic Rings: Enhanced Cytotoxic Activity
H Glasner (2014)
Pharmacological properties of cerium compounds.
M. Jakupec (2005)
Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes.
R. Hamanaka (2010)
Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Alina Shapira (2011)
Optimizing magnetic nanoparticle design for nanothermotherapy.
F. Gazeau (2008)
The Hydrophobic Effect: Formation of Micelles and Biological Membranes
C. Walker (1981)
Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imaging-guided photothermal/photodynamic therapy.
J. Lin (2013)
Optical properties and ultrafast dynamics of metallic nanocrystals.
S. Link (2003)
Nanocarriers as an emerging platform for cancer therapy.
D. Peer (2007)
This paper is referenced by
Microwave Hyperthermia Study in Breast Cancer Treatment
H. Mendez (2019)
Multifunctional nanoemulsions for intraductal delivery as a new platform for local treatment of breast cancer
A. Migotto (2018)
Applied Informatics: Third International Conference, ICAI 2020, Ota, Nigeria, October 29–31, 2020, Proceedings
S. Barbosa (2020)
Using CuO nanoparticles and hyperthermia in radiotherapy of MCF-7 cell line: synergistic effect in cancer therapy
Hadi Esmaeili Govarchin Ghaleh (2019)
Combination of microneedles and microemulsions to increase celecoxib topical delivery for potential application in chemoprevention of breast cancer
Gabriela Mojeiko (2019)
Hyperthermia Study in Breast Cancer Treatment Using a New Applicator
H. F. G. Mendez (2019)
Synthesis and characterization of nanoceria-based composites and in vitro evaluation of their cytotoxicity against colon cancer
Z. Rasouli (2020)
Biomarker selection and imaging design in cancer: A link with biochemical pathways for imminent engineering
Joham Surfraz Ali (2020)